Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05849441 · ClinicalTrials.gov registry record · NA
Mindfulness Program for Adolescents With 22q11DS
A NA study of 22Q11 Deletion Syndrome, sponsored by Innovation Research & Training.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT05849441: Completed NA study of 22Q11 Deletion Syndrome, sponsored by Innovation Research & Training.
NCT05849441 is a NA study of 22Q11 Deletion Syndrome that has completed, run by Innovation Research & Training. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05849441, a NA study of 22Q11 Deletion Syndrome, has completed, sponsored by Innovation Research & Training.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate the effectiveness of the Aware Program, an online mindfulness education program, with adolescents with 22q11DS and their parents.
Primary Outcome
Adolescents will be asked to respond to 34 questions (e.g., Try to think of different ways to solve it; 1 = Never; 5 = Always) that assess their coping in response to stressors across 5 domains: Seeking Social Support, Problem Solving, Distancing, Externalizing, and Internalizing. Three items related to mindfulness skills will be included as a mindfulness subscale. Responses will be averaged across each domain and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indic
Conditions Studied
Interventions
- BEHAVIORAL Aware Program
Study Locations (1)
North Carolina
- innovation Research & Training - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2023-12-18 |
| Est. Completion | 2024-08-17 |
| Phase | NA |
What the finished NCT05849441 record still lists
NCT05849441 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with 22Q11 Deletion Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Aware Program is the first listed.
NCT05849441 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05849441 about?
NCT05849441 is a clinical study titled "Mindfulness Program for Adolescents With 22q11DS". The goal of this study is to evaluate the effectiveness of the Aware Program, an online mindfulness education program, with adolescents with 22q11DS and their parents.
What is the current status of trial NCT05849441?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2023-12-18. Estimated completion is 2024-08-17.
What conditions does trial NCT05849441 study?
This clinical trial studies the following conditions: 22Q11 Deletion Syndrome.
What interventions are being tested in trial NCT05849441?
The interventions under investigation include: Aware Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05849441?
This trial is sponsored by Innovation Research & Training, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05849441 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05849441's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI